Changing practices of red blood cell transfusions in infants with birth weights less than 1000 g

Journal of Pediatrics

Volumn 136, Issue 2, 2000, Pages 220-224

  Maier, Rolf F ^a   Sonatag, Josef ^a   Walka, Mathias M ^a   Liu, Guosheng ^a   Metze, Boris C ^a   Obladen, Michael ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ARTICLE; BLOOD VOLUME; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; INFANT DISEASE; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

EID: 0033929791     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(00)70105-3     Document Type: Article

References (30)

1. 1. Levy GJ, Strauss RG, Hume H, Schloz L, Albanese MA, Blazina J, et al. National survey of neonatal transfusion practices: I. Red blood cell therapy. Pediatrics 1993;91:523-9.
2. 2. Obladen M, Sachsenweger M, Stahnke M. Blood sampling in very low birth weight infants receiving different levels of intensive care. Eur J Pediatr 1988;147:399-404.
3. 3. Shannon KM, Keith III JF, Mentzer WC, Ehrenkranz RA, Brown MS, Widness JA, et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 1995;95:1-8.
4. 4. Sacher RA, Luban NLC, Strauss RG. Current practice and guidelines for the transfusion of cellular blood components in the newborn. Transfus Med Rev 1989;3:39-54.
5. 5. Strauss RG. Transfusion therapy in neonates. AJDC 1991;145:904-11.
6. 6. Widness JA, Seward VJ, Kromer IJ, Burmeister LF, Bell EF, Strauss RG. Changing patterns of red blood cell transfusion in very low birth weight infants. J Pediatr 1996;129:680-7.
7. 7. Obladen M, Maier R, Segerer H, Grauel EL, Holland BM, Stewart G, et al. Efficacy and safety of recombinant human erythropoietin to prevent the anaemias of prematurity. European randomized multicenter trial. Contrib Nephrol 1991;88:314-26.
8. 8. Maier RF, Obladen M, Scigalla P, Linderkamp O, Duc G, Hieronimi G, et al. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. N Engl J Med 1994;330:1173-8.
9. 9. Maier RF, Obladen M, Kattner E, Natzschka J, Messer J, Ragazzoni BM, et al. High-versus low-dose erythropoietin in extremely low birth weight infants. J Pediatr 1998;132:866-70.
10. 10. The International Network. The CRIB (clinical risk index for babies) score: a tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units. Lancet 1993;342:193-8.
11. 11. International Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Pediatrics 1984;74:127-33.
12. 12. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529-34.
13. 13. Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 1986;33:179-201.
14. 14. Strauss RG, Villhauer PJ, Cordle DG. A method to collect, store and issue multiple aliquots of packed red blood cells for neonatal transfusions. Vox Sang 1995;68:77-81.
15. 15. Goodstein MH, Locke RG, Wlodarczyk D, Goldsmith LS, Rubenstein SD, Herman JH. Comparison of two preservation solutions for erythrocyte transfusions in newborn infants. J Pediatr 1993;123:783-8.
16. 16. Strauss RG, Burmeister LF, Johnson K, James T, Miller J, Cordle DG, et al. AS-1 red cells for neonatal transfusions: a randomized trial assessing donor exposure and safety. Transfusion 1996;36:873-8.
17. 17. Liu EA, Mannino FL, Lane TA. Prospective, randomized trial of the safety and efficacy of a limited donor exposure transfusion program for premature neonates. J Pediatr 1994;125:92-6.
18. 18. Wood A, Wilson N, Skacel P, Thomas R, Tidmarsh E, Yale C, de Silva M. Reducing donor exposure in preterm infants requiring multiple blood transfusions. Arch Dis Child 1995;72:F29-33.
19. 19. Ballin A, Arbel E, Kenet G, Berar M, Kohelet D, Tanay A, et al. Autologous umbilical cord blood transfusion. Arch Dis Child 1995;73:F181-3.
20. 20. Bifano EM, Dracker RA, Lorah K, Palit A. Collection and 28-day storage of human placental blood. Pediatr Res 1994;36:90-4.
21. 21. Hume H. Red blood cell transfusions for preterm infants: The role of evidence-based medicine. Sem Perinatol 1997;21:8-19.
22. 22. Jones JG, Holland BM, Hudson IRB, Wardrop CAJ. Total circulating red cells versus haematocrit as the primary descriptor of oxygen transport by the blood. Br J Haematol 1990;76:288-94.
23. 23. Meyer MP, Meyer JH, Commerford A, Hann FM, Sive AA, Moller G, et al. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study. Pediatrics 1994;93:918-23.
24. 24. Bechensteen AG, Haga P, Halvorsen S, Whitelaw A, Liestol K, Lindemann R, et al. Erythropoietin, protein, and iron supplementation and the prevention of aneamia of prematurity. Arch Dis Child 1993;69:19-23.
25. 25. Carnielli V, Montini G, DaRiol R, Dal-l'Amico R, Cantarutti F. Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants. J Pediatr 1992;121:98-102.
26. 26. Emmerson AJB, Coles HJ, Stern CMM, Pearson TC. Double blind trial of recombinant human erythropoietin in preterm infants. Arch Dis Child 1993;68:291-6.
27. 27. Messer J, Haddad J, Donato L, Astruc D, Matis J. Early treatment of premature infants with recombinant human erythropoietin. Pediatrics 1993;92:519-23.
28. 28. Soubasi V, Kremenopoulos G, Diamandi E, Tsantali C, Tsakiris D. In which neonates does early recombinant human erythropoietin treatment prevent anemia of prematurity? Results of a randomized, controlled study. Pediatr Res 1993;34:675-9.
29. 29. Ohls RK, Harcum J, Schibler KR, Christensen RD. The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: a randomized, double-blind, placebo-controlled study. J Pediatr 1997;131:661-5.
30. 30. Ohls RK, Ehrenkranz RA, Lemons JA, Korones SB, Stoll BJ, Stark AR, et al. A multicenter randomized double-masked placebo-controlled trial of early erythropoietin and iron administration to preterm infants. Pediatr Res 1999;45:216A.